299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details
臨床試験数 : 1,696 / 薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00803179 (ClinicalTrials.gov) | November 2008 | 4/12/2008 | Growth Hormone Therapy for Wasting in Cystic Fibrosis | Growth Hormone Therapy for Wasting in Cystic Fibrosis | Cystic Fibrosis | Drug: Nutropin AQ | University of Massachusetts, Worcester | NULL | Terminated | 18 Years | N/A | All | 5 | Phase 1 | United States |
2 | NCT00287443 (ClinicalTrials.gov) | February 2, 2006 | 2/2/2006 | Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis | Cystic Fibrosis | Procedure: Oral Glucose tolerance test;Procedure: Whole body protein turnover;Procedure: IV glucose tolerance test;Procedure: Indirect Calorimetry;Procedure: Dual Energy X-ray Absorptiometry (DEXA);Procedure: Growth Hormone Stimulation Test | University of Texas Southwestern Medical Center | Genentech, Inc. | Withdrawn | 7 Years | 17 Years | All | 0 | N/A | United States | |
3 | NCT00287430 (ClinicalTrials.gov) | January 2006 | 2/2/2006 | Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis | Cystic Fibrosis | Drug: Growth Hormone;Procedure: Whole body Protein Turnover Study;Procedure: Dual Energy X-ray Absorptiometry (DEXA) | University of Texas Southwestern Medical Center | Dana S Hardin | Withdrawn | 6 Years | 40 Years | All | 0 | N/A | NULL | |
4 | NCT00016445 (ClinicalTrials.gov) | February 2001 | 6/5/2001 | Phase II Study of Growth Hormone in Children With Cystic Fibrosis | Cystic Fibrosis | Drug: growth hormone | University of Utah | NULL | Completed | 5 Years | 12 Years | Both | 40 | Phase 2 | United States | |
5 | NCT00005112 (ClinicalTrials.gov) | April 2000 | 15/4/2000 | Growth Hormone Use in Cystic Fibrosis - a Multicenter Study | Cystic Fibrosis | Drug: Human recombinant growth hormone | National Center for Research Resources (NCRR) | Genentech, Inc. | Completed | 5 Years | 12 Years | Both | Phase 3 | United States | ||
6 | NCT00256555 (ClinicalTrials.gov) | February 2000 | 17/11/2005 | Growth Hormone Treatment Study in Children With Cystic Fibrosis | GROWTH HORMONE USE IN CYSTIC FIBROSIS - A MULTICENTER STUDY | Cystic Fibrosis | Drug: Nutropin AQ | University of Texas Southwestern Medical Center | Genentech, Inc. | Withdrawn | 5 Years | 12 Years | All | 0 | Phase 2/Phase 3 | NULL |